Suppliers in Riverhead, NY
11 Medicare Suppliers found. Showing 1 - 11
 Apria Healthcare Llc Durable Medical Equipment & Medical Supplies Location: 1074 Pulaski St 1, Riverhead, New York 11901 Phone: (631) 727-5490 |
Cvs Pharmacy #06026 Durable Medical Equipment & Medical Supplies Location: 1140 Old Country Rd, Riverhead, New York 11901 Phone: (631) 727-9000 |
Cvs Pharmacy #16939 Durable Medical Equipment & Medical Supplies Location: 1150 Old Country Rd, Riverhead, New York 11901 Phone: (631) 208-9354 |
Visionworks Eyewear Supplier (Equipment, not the service) Location: 1820 Old Country Rd, Riverhead, New York 11901 Phone: (631) 208-2927 |
Eastside Orthotics & Prosthetics Durable Medical Equipment & Medical Supplies Location: 889 Harrison Avenue, Riverhead, New York 11901 Phone: (631) 727-8735 |
Jeffrey Nazar Dc Pc Medicare Supplier Location: 189 Main Rd, Riverhead, New York 11901 Phone: (631) 369-4323 |
Lewin Medica; Supply Durable Medical Equipment & Medical Supplies Location: 165 Oliver St, Riverhead, New York 11901 Phone: (631) 727-7006 |
Martin Drugs Of Riverhead Inc Pharmacy Location: 849 Old Country Rd, Riverhead, New York 11901 Phone: (631) 727-0550 |
Sound Vision Care, Inc. Eyewear Supplier (Equipment, not the service) Location: 887 Old Country Rd, Riverhead, New York 11901 Phone: (631) 727-2858 |
Wal Mart Pharmacy 10-2906 Durable Medical Equipment & Medical Supplies Location: 765 Old County Road, Riverhead, New York 11901 Phone: (631) 369-9028 |
Walgreens #9496 Durable Medical Equipment & Medical Supplies Location: 1196 Old Country Rd, Riverhead, New York 11901 Phone: (631) 208-0239 |
News Archive
FDA issues Complete Response Letter for approval of Eisai's rabeprazole sodium extended-release capsules
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
Innovista, Houston Regional ACO partner to improve delivery and quality of healthcare
Innovista Health Solutions, a leading Population Health Management organization enabling providers to successfully participate in value based agreements, has partnered with the newly established Houston Regional Accountable Care Organization, LLC.
Researchers reveal how particular melanoma cells help tumors resist drugs
UNC School of Medicine researchers have pinpointed a set of intriguing characteristics in a previously unknown subpopulation of melanoma cancer cells in blood vessels of tumors. These cells, which mimic non-cancerous endothelial cells that normally populate blood vessels in tumors, could provide researchers with another target for cancer therapies.
Nasdaq rejects Speedus' request for continued listing
On February 2, 2010, Speedus submitted an appeal regarding the Nasdaq staff determination by requesting a hearing with the Nasdaq Hearings Panel (the "Panel"). As a result, a hearing has been scheduled for March 11, 2010, at which time the Panel will consider the plan Speedus has developed for regaining and sustaining compliance with the Rule.
Researchers design more effective version of FDA-approved epilepsy drug with fewer side effects
Researchers at the University of Pittsburgh School of Medicine and Arts & Sciences have designed a more effective version of an FDA-approved epilepsy drug with the potential for fewer side effects, according to a study published on March 22 in Molecular Pharmacology. The experimental agent also could prove to be a treatment for tinnitus and other disorders caused by volatile neural signaling.
› Verified 7 days ago